From Epidemiology and Genetics to Diagnostics, Outcome Measures, and Novel Treatments in Autoimmune Bullous Diseases-Reference-Cited by-同舟云学术

From Epidemiology and Genetics to Diagnostics, Outcome Measures, and Novel Treatments in Autoimmune Bullous Diseases

Published:2014-09 Issue:9 Volume:134 Page:2298-2300
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Ludwig Ralf J.,Borradori Luca,Diaz Luis A.,Hashimoto Takashi,Hertl Michael,Ibrahim Saleh M.,Jonkman Marcel F.,Kitajima Yasuo,Murrell Dédée F.,Schmidt Enno,Shimizu Hiroshi,Stanley John R.,Woodley David T.,Zillikens Detlef

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference22 articles.

1. Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response;Colliou;Sci Transl Med,2013

2. Anti-laminin gamma-1 pemphigoid;Dainichi;Proc Natl Acad Sci USA,2009

3. Severity score indexes for blistering diseases;Daniel;Clin Dermatol,2012

4. Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface;Di Zenzo;J Clin Invest,2012

5. Pemphigus vulgaris autoantibody profiling by proteomic technique;Kalantari-Dehaghi;PLoS ONE,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life in Turkish patients with autoimmune blistering diseases: Reliability and validity of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires;Turkish Journal of Dermatology;2019

2. Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease – specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires;Advances in Medical Sciences;2017-03

3. Psoriasis and autoimmunity;Autoimmunity Reviews;2016-12

4. Outcome measures for autoimmune blistering diseases;The Journal of Dermatology;2015-01